共 50 条
- [1] Practical recommendations on the management of VTE in patients with relapsed/refractory multiple myeloma who are treated with lenalidomide and dexamethasoneHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 96 - 96Palumbo, A.Dimopoulos, M.San Miguel, J.Harousseau, J. L.Attal, M.Hussein, M.Knop, S.Ludwig, H.von Lilienfeld-Toal, M.Sonneveld, P.
- [2] Practical recommendations on the management of non-haematological adverse events in relapsed/refractory multiple myeloma patients treated with lenalidomide/dexamethasoneHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 97 - 97Palumbo, A.Attal, M.Dimopoulos, M.San Miguel, J.Harousseau, J. L.Hussein, M.Knop, S.Ludwig, H.Sonneveld, P.von Lilienfeld-Toal, M.
- [3] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMAHAEMATOLOGICA, 2018, 103 : S116 - S117Cerchione, C.Pareto, A. E.Zacheo, I.Di Perna, M.Nappi, D.Peluso, I.Ferrara, K.Pane, F.Catalano, L.
- [4] Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and DexamethasoneCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 38 - 43San-Miguel, Jesus F.Dimopoulos, Meletios A.Stadtmauer, Edward A.Rajkumar, S. VincentSiegel, DavidBravo, Marie-LaureOlesnyckyj, MartaKnight, Robert D.Zeldis, Jerome B.Harousseau, Jean-LucWeber, Donna M.
- [5] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasoneINTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90Shin, JunghoonLee, Je-JungKim, KihyunMin, Chang-KiLee, Jeong-OkSuh, CheolwonKim, Jin SeokLee, Yoo JinYoon, Sung-SooJo, Jae-CheolLee, Ho SupBang, Soo-MeeLee, Jeong-OkBang, Soo-MeeLee, Je-JungKim, KihyunMin, Chang-KiSuh, CheolwonYoon, Dok HyunKim, Jin SeokLee, Yoo JinMoon, Joon HoYoon, Sung-SooKim, InhoJo, Jae-CheolLee, Ho SupPark, Seong KyuShin, Ho-JinKim, Min KyoungMun, Yeung-ChulLee, Mark HongPark, YongEom, Hyeon SeokKim, Hyo JungIm, Sung NamKim, Sung-HyunDo, Young RokLee, Won SikCho, Su-HeeYi, Jun HoLee, Jae Hoon
- [6] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasoneInternational Journal of Hematology, 2019, 109 : 79 - 90Junghoon ShinJe-Jung LeeKihyun KimChang-Ki MinJeong-Ok LeeCheolwon SuhJin Seok KimYoo Jin LeeSung-Soo YoonJae-Cheol JoHo Sup LeeSoo-Mee Bang
- [7] Lenalidomide plus dexamethasone for relapsed or refractory multiple myelomaNEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132Dimopoulos, MeletiosSpencer, AndrewAttal, MichaelPrince, H. MilesHarousseau, Jean-LucDmoszynska, AnnaSan Miguel, JesusHellmann, AndrzejFacon, ThierryFoa, RobinCorso, AlessandroMasliak, ZvenyslavaOlesnyckyj, MartaYu, ZhinuanPatin, JohnZeldis, Jerome B.Knight, Robert D.
- [8] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaINDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13Dabkara, DeepakBajpai, Jyoti
- [9] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMAHAEMATOLOGICA, 2016, 101 : 787 - 788Ri, M.Suzuki, K.Chou, T.Sugiura, I.Takezako, N.Sunami, K.Ishida, T.Izumi, T.Ozaki, S.Iida, S.
- [10] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myelomaBLOOD CANCER JOURNAL, 2014, 4 : e182 - e182Siegel, D. S.Richardson, P.Dimopoulos, M.Moreau, P.Mitsiades, C.Weber, D.Houp, J.Gause, C.Vuocolo, S.Eid, J.Graef, T.Anderson, K. C.